share_log

EF Hutton Assumes VolitionRX at Buy, Announces Price Target of $6

Benzinga ·  Jun 1, 2023 04:50

EF Hutton analyst Tony Butler assumes VolitionRX (AMEX:VNRX) with a Buy rating and announces Price Target of $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment